This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Stingray Therapeutics, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Innovations of Raman Kumar Kalakuntla
Introduction
Raman Kumar Kalakuntla is a notable inventor based in Telangana, India. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of cancer and infectious diseases. With a total of 2 patents, his work focuses on innovative methods that target specific enzymes to enhance treatment efficacy.
Latest Patents
Kalakuntla's latest patents include groundbreaking work on inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). These patents detail compounds and methods for their preparation and use as therapeutic or prophylactic agents. His research aims to provide new avenues for treating cancer, bacterial, or viral diseases by specifically targeting ENPP1.
Career Highlights
Raman Kumar Kalakuntla is currently associated with Stingray Therapeutics, Inc., where he continues to advance his research and development efforts. His innovative approach has positioned him as a key figure in the therapeutic landscape, particularly in the context of enzyme inhibitors.
Collaborations
Some of his notable coworkers include Srinivas Rao Kasibhatla and Alexis Weston, who contribute to the collaborative efforts in their research initiatives.
Conclusion
Raman Kumar Kalakuntla's work exemplifies the spirit of innovation in the field of therapeutic development. His patents and ongoing research hold promise for significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile